HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cytoplasmic alpha-fetoprotein functions as a co-repressor in RA-RAR signaling to promote the growth of human hepatoma Bel 7402 cells.

Abstract
The role of AFP in the retinoic acid-RAR signaling pathway was investigated in human hepatoma Bel 7402 cells. The results showed that AFP and RAR-beta were co-localized and interacted in cytoplasm. AFP may inhibit translocation of RAR-beta into the nucleus via competitive binding to RAR-beta with ATRA, which was reversed by AFP-siRNA transfection. Our data suggest that the ATRA resistance of Bel 7402 cells is at least in part attributable to their high level of cytoplasmic AFP. Thus, by counteracting the effect of AFP, it may be possible to increase the sensitivity of tumor cells to ATRA.
AuthorsMengsen Li, Hui Li, Chaoying Li, Liyuan Guo, Han Liu, Sheng Zhou, Xinhua Liu, Zhuo Chen, Shuanglin Shi, Jiang Wei, Michael A McNutt, Gang Li
JournalCancer letters (Cancer Lett) Vol. 285 Issue 2 Pg. 190-9 (Nov 28 2009) ISSN: 1872-7980 [Electronic] Ireland
PMID19501957 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • BIRC5 protein, human
  • Inhibitor of Apoptosis Proteins
  • Microtubule-Associated Proteins
  • Receptors, Retinoic Acid
  • Survivin
  • alpha-Fetoproteins
  • Tretinoin
Topics
  • Blotting, Western
  • Carcinoma, Hepatocellular (metabolism)
  • Cell Line, Tumor
  • Cytoplasm (chemistry, metabolism)
  • Drug Resistance, Neoplasm (physiology)
  • Flow Cytometry
  • Humans
  • Immunoprecipitation
  • Inhibitor of Apoptosis Proteins
  • Liver Neoplasms (metabolism)
  • Microtubule-Associated Proteins (biosynthesis)
  • Protein Transport (drug effects, physiology)
  • Receptors, Retinoic Acid (metabolism)
  • Signal Transduction (drug effects, physiology)
  • Survivin
  • Transfection
  • Tretinoin (metabolism, pharmacology)
  • alpha-Fetoproteins (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: